Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesRecent Advances in Intravesical Treatment of Overactive Bladder
LUTS: Lower Urinary Tract Symptoms, 07/17/09
Kuo H–C – Intravesical resiniferatoxin (RTX) instillation and intravesical botulinum toxin A (BoNT–A) injection are two promising treatment alternatives for refractory OAB. BoNT–A, however, has a beneficial effect on detrusor contractility and causes large post–void residual after injection in some patients. Therefore, careful dosage and injection site adjustment is mandatory to achieve satisfactory results using intravesical therapy.
Related Articles
Fesoterodine for the Treatment of Overactive Bladder
Annals of Pharmacotherapy, 11/18/09
Relevance Score: 69%
The importance of bladder wall thickness in the assessment of overactive bladder
Current Bladder Dysfunction Reports, 11/13/09
Relevance Score: 69%
The relationship between sleep apnea and overactive bladder
Current Urology Reports, 11/17/09
Relevance Score: 68%
Efficacy of simplified bladder training in patients with overactive bladder receiving a solifenacin flexible-dose regimen: results from a randomized study
BJU International, 10/13/09
Relevance Score: 68%
Frequently asked questions in the evaluation and management of overactive bladder
The Journal of Family Practice, 11/02/09
Relevance Score: 67%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Combined Resistance and Aerobic Exercise Program Reverses Muscle Loss in Men Undergoing Androgen Suppression Therapy for Prostate Cancer Without Bone Metastases: A Randomized Controlled Trial
Journal of Clinical Oncology, 12/10/09
Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer
Journal of the National Cancer Institute, 12/10/09
Botulinum neurotoxin A for benign prostatic hyperplasia
Current Opinion in Urology, 12/10/09
Today in Voiding Dys/Incontinence...keeping you current
Receive free subspecialty "5-minute updates" via email
Is high diuresis an important prerequisite for successful SWL-disintegration of ureteral stones
Urological Research - Urolithiasis, 12/11/09
Antimuscarinics in men with lower urinary tract symptoms suggestive of bladder outlet obstruction due to benign prostatic hyperplasia
Current Opinion in Urology, 12/11/09
Current status of 5[alpha]-reductase inhibitors in the management of lower urinary tract symptoms and BPH
World Journal of Urology, 12/10/09
Article Search
Sponsor